Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones

Tempus AI, Inc. (NASDAQ:TEM) is one of the champion Nancy Pelosi Stocks to bargain successful 2026. On January 27, Tempus AI, Inc. (NASDAQ:TEM) confirmed that its Immune Profile Score Test accurately predicts diligent outcomes for immune checkpoint inhibitor therapy, compared with accepted biomarkers. Consequently, it continues to show superior predictive accuracy, with a hazard ratio of 0.45.

Source: unsplash

On January 21, Tempus AI introduced Paige Predict, an AI-powered integer pathology instrumentality designed to analyse H&E full descent images and foretell 123 biomarkers crossed 16 crab types, helping clinicians determine which confirmatory tests to tally erstwhile insubstantial samples are limited. Built pursuing Tempus’s 2025 acquisition of Paige, the instrumentality is based connected a instauration exemplary trained connected information from much than 200,000 patients and validated crossed aggregate datasets. Despite operating astatine a loss, Tempus reported a 61.7% gross borderline and says Paige Predict supports its broader extremity of advancing precision medicine by embedding actionable insights straight into objective reports.

Earlier connected January 11, Tempus AI, Inc. announced a grounds Total Contract Value exceeding $1.1 cardinal astatine the extremity of 2025.

The $1.1 cardinal milestone came connected the company’s signing of information agreements with implicit 70 customers spanning ample and midsize companies. Some of the large customers the institution inked deals with see AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, and Novartis. In addition, the institution achieved a nett gross retention of 126%, affirming the strengthening of relationships with existing customers.

“2025 was a grounds twelvemonth for our Data and applications concern – some from a gross and TCV perspective,” said Jim Rogers, Chief Financial Officer astatine Tempus. “Our engagement with beingness sciences companies has ne'er been stronger, and our information concern has ne'er been amended positioned, giving america tremendous visibility to continued maturation successful 2026 and beyond.”

Tempus AI, Inc. (NASDAQ:TEM) is simply a exertion institution that applies artificial quality (AI) to precision medicine, chiefly focusing connected collecting and analyzing objective and molecular information to assistance physicians personalize care.

While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.